Recombinant Human CDCP1 Protein，His

CDCP1 (CUB domain-containing protein 1) is a transmembrane glycoprotein implicated in various physiological and pathological processes, including cell adhesion, migration, and signaling. It has emerged as a significant player in cancer biology, particularly in tumor progression and metastasis. Elevated expression levels of CDCP1 are frequently observed in several types of cancers, correlating with poor prognosis and increased metastatic potential. This has stimulated interest in CDCP1 as a potential biomarker for cancer diagnosis and prognosis. The study of recombinant CDCP1 protein has gained traction, as it allows for the detailed investigation of its structure-function relationships and role in cellular mechanisms. Researchers have utilized techniques such as molecular cloning and expression systems to produce CDCP1 in a purified form, facilitating the exploration of its interactions with other proteins and cell receptors. Understanding how CDCP1 operates at the molecular level may reveal novel therapeutic targets and strategies for cancer treatment. Therefore, the ongoing research on recombinant CDCP1 not only enhances our comprehension of its biological significance but also opens avenues for potential clinical applications, emphasizing the importance of targeting CDCP1 in future cancer therapies.